NIH Updates COVID-19 Treatment Guidance on Corticosteroids, Advance Planning

The National Institutes of Health updated guidance on use of dexamethasone and substitutes in critically ill patients, and on ensuring surrogate decision makers are identified.

The National Institutes of Health (NIH) on July 30, 2020 made updates on use of corticosteroids in treatment of COVID-19 and on approaches to care of the crtically ill, including considerations for advance planning to its dynamic COVID-19 Treatment Guidelines. The guidelines are updated as soon as published data and other authoritative information become available. Following are highlights of the recent updates.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Related Content
© 2023 MJH Life Sciences

All rights reserved.